semaglutide muscle gain GLP-1 and Loss: Semaglutide, Tirzepatide & Lean Mass Medically Managed Semaglutide GLP-1 in

Here are some key factors our providers review with patients to help guide the decision: Your lab results Comprehensive testing of hormone levels reveals if declining growth hormone, testosterone or both are at play

Female patients must strictly avoid pregnancy, use dual forms of reliable contraception, and complete mandatory regular pregnancy tests before and during treatment

Clinical Trials - Key findings Type 2 diabetes (40 weeks): HbA1c 1.241.48% (vs 0.41% placebo) Weight loss 4.57.6% (vs 1.7% placebo) Obesity without diabetes (72 weeks): Mean weight loss 11.2% 54.6% achieved 10% weight loss Improved cardiometabolic markers Efficacy similar to semaglutide/liraglutide (slightly less than tirzepatide) Safety: GI effects most common (during dose escalation) Low discontinuation rates No major hypoglycemia, hepatic, or CV safety signals so far Orforglipron combines oral convenience + GLP-1level efficacy, with the potential to improve access, adherence, and long-term outcomes in diabetes and obesity management

Both Dr